Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Marine sponge-derived and synthetic antitumor compounds patented by Pharma Mar

Oct. 9, 2001

AMDL acquires combination immunogene therapy technology

Oct. 9, 2001

Genmab and Immunex to codevelop antibody therapeutics for lymphoma

Oct. 9, 2001

Pangene's DNA repair protein inhibitors reverse resistance in human cancers

Oct. 9, 2001

Recombinant molecule selected for clinical development as mucositis therapy by Alizyme

Oct. 8, 2001

Enrollment in phase II LDP-341 multiple myeloma trial completed ahead of schedule

Oct. 8, 2001

NeoPharm initiates phase I/II clinical trial for LEM in cancer

Oct. 8, 2001

Folate-based thymidylate synthase inhibitor CW-252053 safe and effective in tumor-bearing mice

Oct. 8, 2001

Additional patient enrollment suspended in phase III study of Aptosyn and Taxotere

Oct. 8, 2001

Apoptotic effect of TAS-106 investigated in human leukemia cells

Oct. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...